Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BeOne
Pharma
Jazz’s Ziihera nets FDA nod in first-line HER2+ stomach cancer
Jefferies analysts recently put Ziihera’s peak sales at $1.5 billion in gastroesophageal adenocarcinoma alone.
Angus Liu
Aug 25, 2026 11:06am
BeOne joins reshoring parade with $300M US production expansion
Jul 23, 2026 11:18am
BeOne’s Brukinsa hits goal in lymphoma confirmatory trial
Jun 30, 2026 6:00am
BeOne boosts support for Blood Cancer United with $5M commitment
Jun 26, 2026 3:57am
Akeso's 34% overall survival win comes with caveats
May 31, 2026 8:00am
Previewing Akeso's high-stakes ASCO plenary for PD-1/VEGF
May 27, 2026 11:25am
